Association of Cerebrovascular Events With Antidepressant Use: A Case-Crossover Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors sought to assess the risk of cerebrovascular events associated with use of antidepressant medications. METHOD: The authors conducted a case-crossover study of 24,214 patients with stroke enrolled in the National Health Insurance Research Database in Taiwan from 1998 to 2007. The authors compared the rates of antidepressant use during case and control time windows of 7, 14, and 28 days. Adjustments were made for time-dependent variables, such as health system utilization and proposed confounding medications. Stratified analyses were performed for valuing the interaction between the stroke risk of antidepressant use and age, sex, presence of mood disorder, stroke type, severity of chronic illness, and duration of antidepressant treatment. A conditional logistic regression model was used to determine the odds of antidepressant use during case time windows. RESULTS: The adjusted odds ratio of stroke risk with antidepressant exposure was 1.48 (95% confidence interval=1.37-1.59) using 14-day time windows. Stroke risk was negatively associated with the number of antidepressant prescriptions reported. Use of antidepressants with high inhibition of the serotonin transporter was associated with a greater risk of stroke than use of other types of antidepressants. CONCLUSIONS: These findings suggest that antidepressant use may be associated with an increased risk of stroke. However, the underlying mechanisms remain unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 2×
“In addition to age and sex, we assessed general health status by the Charlson comorhidity index, which is the sum of the weighted score of 19 comorbid conditions (29) and is widely used to control confounding in epidemiological studies (30).”
MethodThe Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events
Maclure, M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115853 · Cited by 2,327 · cited 2×
“The case-crossover design is one method for examining the effect of transient exposures on acute outcomes (24).”
MethodPharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Psychological distress, major depressive disorder, and risk of stroke
Surtees, P. G., Wainwright, N. W. J., Luben, R. N., Wareham, N. J., Bingham, S. A., & Khaw, K.-T. (2008) · Neurology · doi:10.1212/01.wnl.0000304109.18563.81 · Cited by 183 · cited 1×
“Depression is an independent risk factor for stroke and tbe leading cause of years lost to disability (1-3).”
BackgroundMilnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity
Vaishnavi, S. N., Nemeroff, C. B., Plott, S. J., Rao, S. G., Kranzler, J., & Owens, M. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.006 · Cited by 178 · cited 1×
“For the degree of inhibition of norepinephrine reuptake, we used the K, for the norepinephrine transporter and categorized antidepressants into three groups: high (<100 nmol/liter), intermediate (1001,000 nmol/liter), and low K, (>l,000 nmol/liter) (32, 33).”
MethodSelective Norepinephrine Reuptake Inhibition as a Human Model of Orthostatic Intolerance
Schroeder, C., Tank, J., Boschmann, M., Diedrich, A., Sharma, A. M., Biaggioni, I., Luft, F. C., & Jordan, J. (2002) · Circulation · doi:10.1161/hc0302.102597 · Cited by 127 · cited 1×
“A possible explanation is that high norepinephrine transporter inhibition helps prevent vasovagal reaction (37), which reduces the possibility of hypoperfusion of cerebral circulation and lowers the stroke risk.”
BackgroundIncrease in Antidepressant Medication in the US Adult Population between 1990 and 2003
Mojtabai, R. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112885 · Cited by 100
Cited by
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Treatment response and cognitive impairment in major depression: Association with C-reactive protein
Chang, H. H., Lee, I. H., Gean, P. W., Lee, S.-Y., Chi, M. H., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.239 · Cited by 120
Baumeister, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.025 · Cited by 97
Douros, A., Ades, M., & Renoux, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0507-7 · Cited by 42
Chang, J.-C., Yen, A. M.-F., Lee, C.-S., Chen, S. L.-S., Chiu, S. Y.-H., Fann, J. C.-Y., & Chen, H.-H. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000014 · Cited by 25
Metadata
- Authors
- Wu, C.-S., Wang, S.-C., Cheng, Y.-C., & Gau, S. S.-F.
- Venue
- American Journal of Psychiatry
- Published
- 2011-05
- Volume
- 168
- Issue
- 5
- Pages
- 511-521
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2108029338
- Cited by
- 137
- References
- 7
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of Cerebrovascular Events With Antidepressant Use: A Case-Crossover Study. https://app.cochat.ai/papers/10.1176/appi.ajp.2010.10071064
- The paper
- Wu, C.-S., Wang, S.-C., Cheng, Y.-C., & Gau, S. S.-F. (2011). Association of Cerebrovascular Events With Antidepressant Use: A Case-Crossover Study. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2010.10071064
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.